Articles by Rita Peters - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Rita Peters

Rita Peters

Editorial Director

A Silver Milestone for Drug Development
August 2, 2014

Pharmaceutical Technology Europe marks 25 years of drug-development advances.

Shifting Gears in Drug Development Outsourcing Responsibilities
August 1, 2014

For a bio/pharma industry in flux, contract services are playing a greater—and more diverse—role in drug development.

Benefits and Risks of Drug Information on Social Media
July 2, 2014

FDA draft guidances seek to maintain accurate drug information for patients in new media.

Biopharma Takes a Nervous Glance Over Its Shoulder
May 2, 2014

Changes are needed to maintain US biopharma innovation leadership.

US Biopharma Worries About Losing Lead in Innovation
May 2, 2014

Changes are needed to maintain US biopharma innovation leadership.

Publishing Beyond the Printed Page
April 2, 2014

More media options open publishing opportunities for drug development experts.

Defining Quality Metrics is No Easy Task
February 2, 2014

ISPE and PDA take on the challenge of recommending quality metrics.

2014 Manufacturing Trends and Outlook
January 15, 2014

A survey of BioPharm International readers found that single-use systems and other technologies are driving process efficiencies in biomanufacturing, but there is room for improvement.

New Dynamics in Drug Pricing and Prescribing
January 3, 2014

Generics, market dynamics, and global demand are changing drug-spending patterns.


LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
FindPharma Custom Search
Click here